Prakash Kumar
Rajendra Institute of Medical Sciences
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Prakash Kumar.
Anatolian Journal of Cardiology | 2017
Varun Kumar; Santosh Kumar Sinha; Prakash Kumar; Mohammed Razi; Chandra Mohan Verma; Ramesh Thakur; Umeshwar Pandey; Rajpal Singh Bhardwaj; Mohammed Ahmad; Rk Bansal; Shalini Gupta
Objective: The primary aim of the present study was to evaluate the complications, particularly conduction blocks, subsequent morbidity and mortality, and effect of thrombolytic therapy in Indian patients with inferior wall myocardial infarction (IWMI). Methods: This was a prospective, observational, single-center study conducted at LPS Institute of Cardiology, Kanpur, from December 2011 to May 2014. Patients who presented with typical chest pain and were subsequently diagnosed by standardized diagnostic criteria as having IWMI were enrolled. Patients were grouped on basis of conduction abnormalities, right ventricular (RV) infarction and thrombolytic treatment. Each group was analyzed for comparison of complication profile and mortality. Results: Of 573 patients with IWMI enrolled in the study (mean age: 58.90±12.3 years), 81.2% were male, 225 (39.3%) had conduction blocks, and 189 (32.9%) had RV infarction. In patients with conduction blocks, mortality occurred in 27 patients (12.0%) in contrast to 3.4% of patients without conduction block (p<0.03). Also, there were 27 cases of in-hospital mortality in patients with RV infarction compared with 9 cases in patients without RV infarction (p<0.01). Thrombolytic therapy significantly reduced mortality in patients with IWMI (p<0.001). A significant reduction was observed in cardiogenic shock (p=0.002), severe mitral regurgitation (p=0.007), and left ventricular failure (p<0.001) in patients undergoing thrombolytic therapy. Conclusion: In Indian patients with IWMI, incidence of conduction blocks was higher than previously reported studies. Major complications such as atrioventricular block and RV infarction are associated with increased mortality and poor clinical outcomes. Thrombolytic therapy has a beneficial role in reduction of mortality rate and other complications.
Archive | 2016
Prakash Kumar; V. Venkata Krishna
International journal of scientific research | 2018
Anil Kumar; Amit Kumar; Prakash Kumar; Sushil Kachhap
International journal of biomedical research | 2017
Kusum Kumari; Prakash Kumar
Indian heart journal | 2017
Amit Kumar; Prakash Kumar; Sushil Kachhap; Rajendra Kumar Jha
Indian heart journal | 2017
Amit Kumar; Prakash Kumar; Sushil Kachhap; Rajendra Kumar Jha
cardiology research | 2016
Prakash Kumar; Arijit Das; Satish Chandra; Manju Gari; Umashanker Pd Keshri; Kusum Kumari
cardiology research | 2016
Arijit Das; Prakash Kumar; Abha Kumari; Satish Chandra; Manju Gari; Nidhi Singh; Debleena Dey
cardiology research | 2016
Prakash Kumar; Santosh Kumar Sinha; Umeshwar Pandey; Ramesh Thakur; Chandra Mohan Varma; Mohit Sachan; Amit Goel
cardiology research | 2015
Prakash Kumar; Gaurav Singhal; Santosh Kumar Sinha; Umeshwar Pandey; Ramesh Thakur; Chandra Mohan Varma